References
- Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018;71:1781–1796. doi: 10.1016/j.jacc.2018.02.045
- Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. Treasure Island (FL): StatPearls;
https://www.ncbi.nlm.nih.gov/books/NBK500006/ (5 Jun 2023) - Nappi A, Murolo M, Sagliocchi S, et al. Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior. Int J Mol Sci. 2021;22(13):7175. doi: 10.3390/ijms22137175
- Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014;26(6):296–309. doi: 10.1016/j.arteri.2014.07.003
- von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect. 2019;8(5):R76–R90. doi: 10.1530/EC-19-0096
- Arslan A, Altay H. Graves’ Disease and Cardiac Complications [Internet]. Graves’ Disease. IntechOpen; 2021. doi: 10.5772/intechopen.97128
- López Ortega JM, Martínez PS, Acevedo-León D, Capell NE. Anti-TSH receptor antibodies (TRAb): Comparison of two third-generation automated immunoassays broadly used in clinical laboratories and results interpretation. PLoS One. 2022;17(7):e0270890. doi: 10.1371/journal.pone.0270890
- Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. doi: 10.1097/HJH.0000000000003480
- Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018;7(4):167–186. doi: 10.1159/000490384
- Abdi H, Amouzegar A, Azizi F. Antithyroid Drugs. Iran J Pharm Res. 2019 Fall;18(Suppl1):1–12. doi: 10.22037/ijpr.2020.112892.14005
- Ngassam E, Azabji-Kenfack M, Tankeu AT, et al. Heart rate variability in hyperthyroidism on sub Saharan African patients: a case–control study. BMC Res Notes. 2018;11(1):814. doi: 10.1186/s13104-018-3922-4
- Kotadia ID, Williams SE, O'Neill M. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med. 2020;20(1):43–47. doi: 10.7861/clinmed.cme.20.1.3
- Henning A, Krawiec C. Sinus Tachycardia. In: StatPearls [Internet]. Treasure Island (FL).
https://www.ncbi.nlm.nih.gov/books/NBK553128/ (5 Mar 2023) - Navarro-Navajas A, Cruz JD, Ariza-Ordoñez N, et al. Cardiac manifestations in hyperthyroidism. Rev Cardiovasc Med. 2022;23(4):135–136. doi: 10.31083/j.rcm2304136
- Brugada J, Katritsis DG, Arbelo E, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655–720. doi: 10.1093/eurheartj/ehz467
- Elias RM, Dean DS, Barsness GW. Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience ISRN Endocrinol. 2012;2012:325092. doi: 10.5402/2012/325092
- Abdulrahman RM, Delgado V, Ng AC, et al. Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging. Eur J Endocrinol. 2010;163(3):435–441. doi: 10.1530/EJE-10-0328
- Lanspa MJ, Shahul S, Hersh A, et al. Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients. Ann Intensive Care. 2017;7(1):17. doi: 10.1186/s13613-017-0240-2